|
|
|
Volumn 21, Issue 1 B, 2001, Pages 571-574
|
|
Treatment of classical type kaposi's sarcoma with paclitaxel
|
|
Author keywords
Classical type Kaposi's sarcoma (KS); Paclitaxel
|
|
Indexed keywords
ALPHA2B INTERFERON;
BLEOMYCIN;
DACARBAZINE;
DACTINOMYCIN;
DEXAMETHASONE;
EPIRUBICIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
INTERFERON;
PACLITAXEL;
RANITIDINE;
VINBLASTINE;
VINCRISTINE;
VINCRISTINE SULFATE;
AGED;
ANOREXIA;
ARTICLE;
BONE PAIN;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CLINICAL FEATURE;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG EFFICACY;
FATIGUE;
HISTOPATHOLOGY;
HUMAN;
KAPOSI SARCOMA;
MALE;
PRIORITY JOURNAL;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VERTIGO;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
DACARBAZINE;
DACTINOMYCIN;
DEXAMETHASONE;
DISEASE PROGRESSION;
DRUG RESISTANCE, NEOPLASM;
EPIRUBICIN;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HIV SERONEGATIVITY;
HUMANS;
INTERFERON ALFA-2B;
MALE;
PACLITAXEL;
RANITIDINE;
REMISSION INDUCTION;
SARCOMA, KAPOSI;
SKIN NEOPLASMS;
VINBLASTINE;
VINCRISTINE;
|
|
EID: 0035056440
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (15)
|
|
References (22)
|
